Brendan Hannah
Director of Finance/CFO bei QUINCE THERAPEUTICS, INC.
Vermögen: 213 648 $ am 31.03.2024
Profil
Brendan Hannah is currently the COO, Chief Financial & Accounting Officer at Quince Therapeutics, Inc. and also holds the position of Chief Operating Officer at Novosteo, Inc. Previously, he worked as the Director of Business Development at Cidara Therapeutics, Inc. and as the Chief Business Officer at Neuroptika, Inc. Mr. Hannah obtained an MBA from the University of California.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 201 555 ( 0,47% ) | 213 648 $ | 31.03.2024 |
Aktive Positionen von Brendan Hannah
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director of Finance/CFO | 16.03.2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Brendan Hannah
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Brendan Hannah
| University of California | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
